Clinical Trial

Nuwiq Dosing and Outcomes In the ManagEment of Women/Girls With Haemophilia A Needing FVIII Treatment for Surgery

Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
Recombinant factor VIII for the prevention of bleeding in women/girls with haemophilia A undergoing major surgery
Protocol Amendment History 10 amendments
This ClinicalTrials.gov record has been amended 10 times since 2023-07-03; most recent amendment 2026-05-08.
Status change: Not Yet Recruiting → Recruiting 2024-07-18
Trial Details
NCT Number NCT05936580
Lead Sponsor Octapharma
Conditions Hemophilia A
Enrollment 28 participants
Start Date 2026-04
Primary Completion 2027-02 (estimated)
Study Completion 2027-02 (estimated)
Updated on ClinicalTrials.gov 2026-05-12